OneSource Specialty Pharma to Meet Analysts/Investors on Sep 3, 2026
OneSource Specialty Pharma Limited will host a Group Investor Meeting on September 3, 2026, at its manufacturing facility in Doddaballapura, Bengaluru. The meeting will cover publicly available information like business overview and strategy. No unpublished price sensitive information will be disclosed.
This is a routine investor engagement activity. The announcement pertains to discussions of publicly available information and does not involve any material new developments, financial results, or strategic decisions that would significantly impact the company's stock price or operations.
The announcement is a routine disclosure of an upcoming investor meeting and does not contain any new financial information or strategic shifts that would indicate a positive or negative sentiment. It is a standard communication for investor relations.
OneSource Specialty Pharma Limited will be holding a Group Investor Meeting on Thursday, September 03, 2026. The meeting is scheduled to take place at the company's manufacturing facility, OneSource Unit 2, located at Division Plot# 2-D 1, Obadenahalli, Doddaballapura, 3rd Phase Industrial Area, Doddaballapura Taluk, Bengaluru Rural District - 561203, India.
During this physical meeting, representatives of the company will engage with a group of analysts and investors. The discussions will revolve around publicly available information, including the company's business overview, strategy, industry trends, and growth outlook, as part of ongoing investor engagement efforts. The company has clarified that no unpublished price sensitive information (UPSI) will be shared during these interactions.
This intimation is provided in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
A plain-language summary of a public exchange filing by Onesource Specialty Pharma Limited. Read the original for the full detail.